Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Assets (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Other Non-Current Assets came in at $40495.0 in Q4 2025, up 12.52% on a QoQ basis from $35989.7 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Assets (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Other Non-Current Assets data on file, last reported at $40495.0 in Q4 2025.
- Quarterly Other Non-Current Assets changed N/A year-over-year to $40495.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $40495.0 (changed N/A YoY) and the FY2025 annual result came in at $36851.0, up 14.76% from the prior year.
- Other Non-Current Assets climbed to $40495.0 in Q4 2025, from $35989.7 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $40495.0 in Q4 2025 to a low of $32112.4 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 4.13 Mn | 4.08 Mn | - | 500,038.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 40,495.00 |
| Apr 30, 2025 | 35,989.75 |
| Apr 30, 2024 | 32,112.36 |